Loxo Oncology Announces First Quarter 2017 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/21/2026
- Wall St rises in broad rebound; yields push markets towards weekly declines
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Supermicro probe finds no senior management link to export violations
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Hertz Global amends voting agreement with CK Amarillo after lawsuit
- SpaceX shares fall as second lockup period ends
Loxo Oncology (LOXO) Reports Q1 Loss of $0.96/Share
May 9, 2017 6:59 AM EDTLoxo Oncology (NASDAQ: LOXO) reported Q1 EPS of ($0.96), versus ($0.59) reported last year.
For earnings history and earnings-related data on Loxo Oncology (LOXO) click here.
... More